Health TrialsbyHealthPanel

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Ulcerative Pyoderma Gangrenosum

This study was designed to assess the therapeutic efficacy and safety of SHR-1139 Injection in adult patients with ulcerative pyoderma gangrenosum.

Participants needed: 10
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shandong First Medical UniversityUpdated: Sep 9, 2026Locations: 1
Eligibility criteria

Male or female, age ≥ 18 years old at the time of signing the informed consent f... [+5]

At screening, the clinical manifestations are other ulcers or other similar skin... [+5]

Read more
Status: Recruiting

A Study to Evaluate CM336 in Adults With Autoimmune Bullous Disease

to Evaluate the Efficacy and Safety of CM336 (BCMA/CD3 Bispecific Antibody) in Adults with Moderate to Severe Autoimmune Bullous Disease

Participants needed: 30
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Shandong First Medical UniversityUpdated: Apr 6, 2026Locations: 1
Eligibility criteria

1. Confirmed diagnosis of autoimmune bullous disease； [+2]

1. History of clinically significant diseases that, in the investigator's judgme... [+3]

Read more
Status: Recruiting

Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome

This study is a prospective, multicentre, randomized, open-label, blinded-endpoint clinical trial to evaluate the efficacy and safety of Yangxinshi tablets in the treatment of patients with chronic coronary syndrome (CCS).

Participants needed: 1,200
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: Shandong First Medical UniversityUpdated: Apr 17, 2024Locations: 32
Eligibility criteria

age 18-75 years; [+3]

absolute or relative contraindications for the treadmill cardiopulmonary exercis... [+3]

Read more
Status: Recruiting

Prospective Coronary Heart Disease Cohort

To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.

Participants needed: 50,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Shandong First Medical UniversityUpdated: Feb 13, 2023Locations: 1
Eligibility criteria

Diagnosed as coronary heart disease or with unexplained chest pain needed to und... [+1]

With malignant tumors, infectious diseases and advanced liver diseases. [+1]

Read more